Type 2 diabetes treatment has shifted to a comorbidity-drive…
Type 2 diabetes treatment has shifted to a comorbidity-driven, outcome-focused approach. Under current ADA guidelines, when is a GLP-1 receptor agonist or SGLT-2 inhibitor indicated as FIRST-LINE therapy, even without prior metformin?